229 related articles for article (PubMed ID: 11149415)
21. Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinoma.
Baldinu P; Cossu A; Manca A; Satta MP; Pisano M; Casula M; Dessole S; Pintus A; Tanda F; Palmieri G
Cancer; 2002 Jun; 94(12):3157-68. PubMed ID: 12115348
[TBL] [Abstract][Full Text] [Related]
22. Considerations when analyzing the methylation status of PTEN tumor suppressor gene.
Zysman MA; Chapman WB; Bapat B
Am J Pathol; 2002 Mar; 160(3):795-800. PubMed ID: 11891178
[TBL] [Abstract][Full Text] [Related]
23. Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis.
Martini M; Ciccarone M; Garganese G; Maggiore C; Evangelista A; Rahimi S; Zannoni G; Vittori G; Larocca LM
Int J Cancer; 2002 Dec; 102(4):398-406. PubMed ID: 12402310
[TBL] [Abstract][Full Text] [Related]
24. PTEN mutations and evolving concepts in endometrial neoplasia.
Latta E; Chapman WB
Curr Opin Obstet Gynecol; 2002 Feb; 14(1):59-65. PubMed ID: 11801878
[TBL] [Abstract][Full Text] [Related]
25. The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma.
Konopka B; Janiec-Jankowska A; Paszko Z; Goluda M
J Cancer Res Clin Oncol; 2004 Feb; 130(2):114-21. PubMed ID: 14663583
[TBL] [Abstract][Full Text] [Related]
26. PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations.
Velasco A; Bussaglia E; Pallares J; Dolcet X; Llobet D; Encinas M; Llecha N; Palacios J; Prat J; Matias-Guiu X
Hum Pathol; 2006 Nov; 37(11):1465-72. PubMed ID: 16949921
[TBL] [Abstract][Full Text] [Related]
27. PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases.
Bussaglia E; del Rio E; Matias-Guiu X; Prat J
Hum Pathol; 2000 Mar; 31(3):312-7. PubMed ID: 10746673
[TBL] [Abstract][Full Text] [Related]
28. Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias.
Konopka B; Paszko Z; Janiec-Jankowska A; Goluda M
Cancer Lett; 2002 Apr; 178(1):43-51. PubMed ID: 11849740
[TBL] [Abstract][Full Text] [Related]
29. Colorectal carcinomas and PTEN/MMAC1 gene mutations.
Dicuonzo G; Angeletti S; Garcia-Foncillas J; Brugarolas A; Okrouzhnov Y; Santini D; Tonini G; Lorino G; De Cesaris M; Baldi A
Clin Cancer Res; 2001 Dec; 7(12):4049-53. PubMed ID: 11751500
[TBL] [Abstract][Full Text] [Related]
30. PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers.
Zhou XP; Loukola A; Salovaara R; Nystrom-Lahti M; Peltomäki P; de la Chapelle A; Aaltonen LA; Eng C
Am J Pathol; 2002 Aug; 161(2):439-47. PubMed ID: 12163369
[TBL] [Abstract][Full Text] [Related]
31. Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis.
Velickovic M; Delahunt B; McIver B; Grebe SK
Mod Pathol; 2002 May; 15(5):479-85. PubMed ID: 12011252
[TBL] [Abstract][Full Text] [Related]
32. Abnormal structure and expression of PTEN/MMAC1 gene in human uterine cancers.
Yaginuma Y; Yamashita T; Ishiya T; Morizaki A; Katoh Y; Takahashi T; Hayashi H; Ishikawa M
Mol Carcinog; 2000 Feb; 27(2):110-6. PubMed ID: 10657903
[TBL] [Abstract][Full Text] [Related]
33. Methylation of hMLH1 in a population-based series of endometrial carcinomas.
Salvesen HB; MacDonald N; Ryan A; Iversen OE; Jacobs IJ; Akslen LA; Das S
Clin Cancer Res; 2000 Sep; 6(9):3607-13. PubMed ID: 10999752
[TBL] [Abstract][Full Text] [Related]
34. Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma.
Pallarés J; Velasco A; Eritja N; Santacana M; Dolcet X; Cuatrecasas M; Palomar-Asenjo V; Catasús L; Prat J; Matias-Guiu X
Mod Pathol; 2008 Jun; 21(6):691-9. PubMed ID: 18469797
[TBL] [Abstract][Full Text] [Related]
35. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas.
Catasús L; Bussaglia E; Rodrguez I; Gallardo A; Pons C; Irving JA; Prat J
Hum Pathol; 2004 Nov; 35(11):1360-8. PubMed ID: 15668893
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic and genetic alternation of PTEN in cervical neoplasm.
Cheung TH; Lo KW; Yim SF; Chan LK; Heung MS; Chan CS; Cheung AY; Chung TK; Wong YF
Gynecol Oncol; 2004 Jun; 93(3):621-7. PubMed ID: 15196854
[TBL] [Abstract][Full Text] [Related]
37. PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics.
Risinger JI; Hayes K; Maxwell GL; Carney ME; Dodge RK; Barrett JC; Berchuck A
Clin Cancer Res; 1998 Dec; 4(12):3005-10. PubMed ID: 9865913
[TBL] [Abstract][Full Text] [Related]
38. PTEN expression in tamoxifen-associated endometrial cancers.
Holtz D; Ramondetta LM; Burke TW; Palazzo JP; Dunton CJ; Atkinson EN; Broaddus RR
Anticancer Res; 2002; 22(5):2945-8. PubMed ID: 12530022
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities.
Pallares J; Bussaglia E; Martínez-Guitarte JL; Dolcet X; Llobet D; Rue M; Sanchez-Verde L; Palacios J; Prat J; Matias-Guiu X
Mod Pathol; 2005 May; 18(5):719-27. PubMed ID: 15578076
[TBL] [Abstract][Full Text] [Related]
40. Somatic mutations of the PTEN/MMAC1 gene in fifteen Japanese endometrial cancers: evidence for inactivation of both alleles.
Kurose K; Bando K; Fukino K; Sugisaki Y; Araki T; Emi M
Jpn J Cancer Res; 1998 Aug; 89(8):842-8. PubMed ID: 9765621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
